Decision makers from European pharma and biotech companies will hear from two speakers at Connect in Pharma, Jean-François Hilaire (Recipharm) and Christian Wölbeling (Körber Pharma Software), on how to ensure a strong future in European pharma.
Key highlights:
- The announced agenda for Connect in Pharma focuses on innovation as the foundation of a strong pharmaceutical industry in Europe.
- Hilaire's talk will make the case that Europe must hold onto production of any new innovative products, such as the mRNA-based medicines and more generally the large-molecule biologics of the future.
- Wölbeling will present insights on how organisations need to transform from the ground up to leverage the full potential of digitalisation.
- Other speakers from BD, Roche, Unither Pharmaceuticals, UPSA, Gerresheimer and elsewhere will speak on a range of topics, including how to scale up biotech products and innovations in injectables.
To ensure a strong future for European pharma, businesses need to prioritise digitalisation and maintain control of production lines, say two industry experts due to speak at Connect in Pharma in September.